Intended Audience:
The educational activity is designed for physicians
likely to encounter patients at risk for VTE, among
them: primary care physicians, hospitalist physicians,
critical care specialists/intensivists, orthopedic
surgeons, general surgeons, hematologists,
pulmonologists, thrombosis medicine anticoagulation
specialists, hospital-focused internists, surgical oncologists,
and emergency medicine specialists.
Registration:
Enrollment for this webcast is complimentary, and clinicians are invited to participate in this CME-certified webcasts and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.
Grantor Support:
Supported by an independent educational grant from Eisai , Inc
Designation of Credit:
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS). The UMMS is accredited by ACCME to provide continuing medical education for physicians.
The UMMS designates this continuing medical education activity for up to 3 credit hours in Category 1 toward the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
Statement of Disclosure:
In accordance with the Standards of the Accreditation Council for Continuing Medical Education (ACCME) and the guidelines of the Association of American Medical Colleges (AAMC), it is the policy of the University of Massachusetts Medical School to disclose whatever interest or affiliation a speaker might have with any commercial organization whose products or services are related to the subject matter being presented.
Faculty Disclosures
Samuel Z. Goldhaber, MD
Grant/Research Support: sanofi-aventis, Astra-Zeneca, GSK, Eisai, Mitsubishi
Consultant: sanofi-aventis, Bayer, BMS, Boehringer-Ingelheim
Russell Hull, MBBS, MSc
Grant/Research Support: sanofi-aventis, Bayer
Consultant: sanofi-aventis, Bayer, Wyeth, GSK
Craig M. Kessler, MD
Grant/Research Support: sanofi-aventis, Pfizer, GSK
Consultant: sanofi-aventis, GSK
Speaker's Bureau: sanofi-aventis, GSK
Program Faculty
Samuel Z. Goldhaber, MD
Program Chairman and Series Medical Director
Professor of Medicine, Cardiovascular Division
Harvard Medical School
Director, Venous Thramboembolism
Research Group
Director, Anticoagulation Service
Brigham and Women's Hospital
Boston, MA
Russell Hull, MBBS, MSc
Professor of Medicine
Director, Thrombosis Research Unit
University of Calgary
Calgary, Alberta Canada
Craig M. Kessler, MD
Professor of Medicine and Pathology
Georgetown University Medical Center
Chief of the Division of Hematology-Oncology
Director of the Division of Coagulation
Department of Laboratory Medicine
Washington, DC
Educational Objectives:
- Clinicians will learn how to apply current guidelines
issued by national professional organizations and
colleges, such as the ACCP, mandating risk-directed
prophylaxis against DVT in at risk patients with medical
and surgical conditions.
- Clinicians will learn to risk stratify medical and surgical
patients, assess their liklihood for incurring DVT, and be
aware of prophylaxis measures that can reduce the incidence
of DVT in the patient populations.
- Clinicians will learn to assess and manage special needs
of cancer patients at risk for DVT, with a focus on protecting
against recurrent DVT.
- Clinicians will learn to risk stratify patients undergoing
general and orthopedic surgery, and implement ACCP-mandated
pharmacologic and non-pharmacologic measures aimed at DVT
prophylaxis.
- Clinicians will learn how to apply landmark clinical
trials focusing on DVT prevention in medical and surgical
patients to their clinical practice.
- Clinicians will learn how to evaluate, select among, and
appropriately use the range of pharmacologic options available
for DVT prophylaxis, including warfarin, unfractionated heparin,
and LMWHs.
Disclaimer
Copyright © 2006 by Pharmatecture, LLC. All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited.
Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
Opinions expressed herein are not necessarily those of Pharmatecture, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.
Copyright (c) 2006 All rights reserved including
